Alto Neuroscience Securities Fraud Lawsuit Deadline for Investors with Losses Over $100K

A securities fraud lawsuit has been filed against Alto Neuroscience, Inc. (NYSE: ANRO) for allegedly making false and misleading statements regarding its business, operations, and prospects. Investors who purchased Alto securities during the IPO or between February 2, 2024, and October 22, 2024, may be entitled to compensation. The lead plaintiff deadline is September 19, 2025.

A securities fraud lawsuit has been filed against Alto Neuroscience, Inc. (NYSE: ANRO) for allegedly making false and misleading statements regarding its business, operations, and prospects. The lawsuit, which seeks to recover losses on behalf of investors, was filed by Rosen Law Firm [1] and Levi & Korsinsky, LLP [2].

The complaint alleges that during the Class Period, which spans from February 2, 2024, to October 22, 2024, the company made materially false and misleading statements about its product pipeline, ALTO-100. Specifically, it is claimed that ALTO-100 was less effective in treating major depressive disorder than represented, leading to overstated clinical, regulatory, and commercial prospects. As a result, the company's business and financial prospects were also overstated, and its public statements were materially false and misleading.

Investors who purchased Alto securities during the IPO or within the Class Period may be entitled to compensation. The lead plaintiff deadline for this lawsuit is September 19, 2025. Investors are encouraged to review the details and consider their options, as they may be able to participate in the lawsuit without incurring any out-of-pocket costs or fees.

Rosen Law Firm and Levi & Korsinsky, LLP have extensive experience in securities litigation and have secured significant settlements for investors in the past. Rosen Law Firm, for instance, has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. Levi & Korsinsky has also secured hundreds of millions of dollars for shareholders and has been ranked in the Top 50 Report by ISS Securities Class Action Services for seven consecutive years.

For more information, investors can visit the respective law firms' websites or contact the listed attorneys.

References:
[1] https://www.prnewswire.com/news-releases/anro-deadline-anro-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-alto-neuroscience-inc-securities-fraud-lawsuit-302542395.html
[2] https://www.globenewswire.com/news-release/2025/08/25/3138899/3080/en/Alto-Neuroscience-Inc-Securities-Fraud-Class-Action-Lawsuit-Pending-Contact-Levi-Korsinsky-Before-September-19-2025-to-Discuss-Your-Rights-ANRO.html